Jun.-Prof. Dr. Peter Loskill is Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University Tübingen and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science. He then spent three years in the laboratory of Prof. K. E. Healy at the University of California at Berkeley. There, he worked as a postdoctoral fellow and project leader, funded by the NIH NCATS TissueChip program and the German Science Foundation, and developed organ-on-a-chip (OoC) systems based on human iPS-cell technology. In 2015, he was named as one of Technology Review’s “Innovators under 35 Germany” and was awarded a Fraunhofer ATTRACT Grant, the highest funded German starting grant program, which enabled him to start an independent research group at Fraunhofer IGB. His µOrgano lab now focuses on i) the development of human microphysiological OoC systems, ii) on the application of OoC for pharmaceutical research, toxicological screening, and mechanistic studies, specifically towards woman’s health, as well as iii) on the development of enabling technologies for OoC that support parallelization, automation and ease of use. To advance OoC research in Europe, he currently coordinates the European training network (MSCA-ITN) EUROoC, works on an OoC roadmap within H2020-FET-Open ORCHID, and serves as the vice-chair and founding member of the European OoC Society (EUROoCS).